EUVIMEDEUVIMED entdecken
Open Access

Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody–drug Conjugates Using Pharmacovigilance Databases

Kousuke Hosonaka, Kenta Yamaoka, Mayako Uchida, Yoshihiro Uesawa, Kazushige Takahashi, Tadashi Shimizu

In Vivo · 2026-07 · 40 (4) · 2093-2106

DOI: 10.21873/invivo.14362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 30.06.2026. Verfasst von Kousuke Hosonaka und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hyogo Medical University, Kobe, Japan. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Immunoconjugates, Pharmacovigilance, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesImmunoconjugatesPharmacovigilanceDrug-Related Side Effects and Adverse ReactionsAntineoplastic Agents, ImmunologicalHumansFemaleAntibodies, Monoclonal, HumanizedAdo-Trastuzumab EmtansineAdverse Drug Reaction Reporting SystemsTrastuzumabDatabases, FactualMiddle AgedMaleAgedAdultCamptothecin

Stichwörter der Autor:innen

Antibody-drug conjugateJapanese Adverse Drug Event Reportdisproportionality analysispharmacovigilancetrastuzumab deruxtecantrastuzumab emtansine

Substanzen

Erb-b2 Receptor Tyrosine KinasesImmunoconjugatesAntibodies, Monoclonal, HumanizedAdo-Trastuzumab EmtansineERBB2 protein, humanTrastuzumabtrastuzumab deruxtecanAntineoplastic Agents, ImmunologicalpertuzumabCamptothecin

Autor:innen und Institutionen

  • School of Pharmacy, Hyogo Medical University, Kobe, Japan.
  • Department of Pharmacy, Osaka-fu Saiseikai Noe Hospital, Osaka, Japan.
  • Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan.
  • Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo, Japan.
  • School of Pharmacy, Hyogo Medical University, Kobe, Japan; shimizu-t@hyo-med.ac.jp.

Zitieren

APA

Hosonaka, K., Yamaoka, K., Uchida, M., Uesawa, Y., Takahashi, K., & Shimizu, T. (2026). Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody–drug Conjugates Using Pharmacovigilance Databases. In Vivo, 40(4), 2093-2106. https://doi.org/10.21873/invivo.14362

Vancouver

Hosonaka K, Yamaoka K, Uchida M, Uesawa Y, Takahashi K, Shimizu T. Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody–drug Conjugates Using Pharmacovigilance Databases. In Vivo. 2026;40(4):2093-2106. doi:10.21873/invivo.14362

BibTeX
@article{Hosonaka2026,
  author = {Hosonaka, Kousuke and Yamaoka, Kenta and Uchida, Mayako and Uesawa, Yoshihiro and Takahashi, Kazushige and Shimizu, Tadashi},
  title = {Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody–drug Conjugates Using Pharmacovigilance Databases},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {4},
  pages = {2093--2106},
  doi = {10.21873/invivo.14362}
}
Kostenlos starten →